Scattoni Vincenzo, Roscigno Marco, Freschi Massimo, Briganti Alberto, Fantini Gemma Viola, Bertini Roberto, Salonia Andrea, Montorsi Francesco, Rigatti Patrizio
Department of Urology, Vita-Salute University, School of Medicine, San Raffaele Hospital, Milan, Italy.
Urology. 2005 Nov;66(5):1043-7. doi: 10.1016/j.urology.2005.05.006.
To evaluate the factors that predict prostate cancer detection by means of 10 to 12 core repeat biopsies in patients with atypical small acinar proliferation (ASAP) results on initial biopsy.
From 1998 to 2004, 110 of 127 patients (87%) with a diagnosis of ASAP were rebiopsied with the same technique plus additional biopsies on the ASAP site (12.6 +/- 1.1 cores [mean +/- standard deviation]). Each histologic slide was reviewed blindly by a single experienced pathologist, who also differentiated highly suspicious (ASAPH) and not highly suspicious (ASAPB) lesions for cancer.
On initial biopsy, a concomitant high-grade prostatic intraepithelial neoplasia (HGPIN) was present in 26 patients (23%) with ASAP. The overall cancer detection rate was significantly higher in patients who had ASAP associated with HGPIN (58%), compared with patients who had isolated ASAP (35%; P = 0.04). The cancer detection rate was not significantly higher in patients with ASAPH than in those with ASAPB (49% versus 33%, respectively; P = 0.11). In the group of patients who had isolated ASAP, the rate of cancer detection was significantly higher in patients who had a prostatic volume less than 50 mL (56%) than in patients with a prostatic volume of 50 mL or more (27%; P = 0.03).
The cancer detection rate was significantly higher in patients with an ASAP associated with HGPIN on initial biopsy than in patients with isolated ASAP. In ASAP patients, the detection rate was lower for patients with a larger prostate than in those with a smaller prostate.
评估在初次活检结果为非典型小腺泡增生(ASAP)的患者中,通过10至12针重复活检来检测前列腺癌的预测因素。
1998年至2004年期间,127例诊断为ASAP的患者中有110例(87%)接受了相同技术的再次活检,并在ASAP部位额外进行活检(12.6±1.1针[平均值±标准差])。每例组织学切片由一位经验丰富的病理学家进行盲法评估,该病理学家还区分了高度可疑(ASAPH)和非高度可疑(ASAPB)的癌症病变。
初次活检时,26例(23%)ASAP患者伴有高级别前列腺上皮内瘤变(HGPIN)。与孤立性ASAP患者(35%)相比,伴有HGPIN的ASAP患者总体癌症检出率显著更高(58%;P = 0.04)。ASAPH患者的癌症检出率并不显著高于ASAPB患者(分别为49%和33%;P = 0.11)。在孤立性ASAP患者组中,前列腺体积小于50 mL的患者癌症检出率(56%)显著高于前列腺体积为50 mL或更大的患者(27%;P = 0.03)。
初次活检时伴有HGPIN的ASAP患者的癌症检出率显著高于孤立性ASAP患者。在ASAP患者中,前列腺较大者的检出率低于前列腺较小者。